HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 316 filers reported holding HAEMONETICS CORP in Q2 2024. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,436,397 | -3.2% | 53,625 | -0.1% | 0.01% | -7.1% |
Q1 2024 | $4,581,161 | -50.1% | 53,675 | -50.0% | 0.01% | -6.7% |
Q4 2023 | $9,183,774 | +97.2% | 107,400 | +106.5% | 0.02% | -6.2% |
Q3 2023 | $4,658,160 | +3.6% | 52,000 | -1.5% | 0.02% | +6.7% |
Q2 2023 | $4,495,392 | +19.9% | 52,800 | +16.6% | 0.02% | +15.4% |
Q1 2023 | $3,748,575 | +1078.8% | 45,300 | +906.7% | 0.01% | +1200.0% |
Q3 2021 | $318,000 | -69.9% | 4,500 | -52.6% | 0.00% | -66.7% |
Q1 2021 | $1,055,000 | -6.5% | 9,500 | 0.0% | 0.00% | -25.0% |
Q4 2020 | $1,128,000 | +36.1% | 9,500 | 0.0% | 0.00% | +33.3% |
Q3 2020 | $829,000 | -57.1% | 9,500 | -56.0% | 0.00% | -25.0% |
Q2 2020 | $1,934,000 | -10.1% | 21,600 | 0.0% | 0.00% | -20.0% |
Q1 2020 | $2,152,000 | +126.3% | 21,600 | +1.9% | 0.01% | +25.0% |
Q3 2017 | $951,000 | +225.7% | 21,200 | +194.4% | 0.00% | +300.0% |
Q1 2017 | $292,000 | -53.8% | 7,200 | -67.0% | 0.00% | -66.7% |
Q2 2016 | $632,000 | – | 21,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Black Creek Investment Management Inc. | 1,014,941 | $33,077,000 | 3.62% |
Camber Capital Management LP | 1,202,000 | $39,173,000 | 3.07% |
AMERICAN CAPITAL MANAGEMENT INC | 718,380 | $23,412,000 | 2.76% |
Van Berkom & Associates Inc. | 1,258,322 | $41,009,000 | 2.31% |
SNYDER CAPITAL MANAGEMENT L P | 1,222,547 | $39,843,000 | 2.07% |
KESTREL INVESTMENT MANAGEMENT CORP | 441,250 | $14,380,000 | 1.78% |
STONE RUN CAPITAL, LLC | 33,740 | $1,100,000 | 0.80% |
HERMES INVESTMENT MANAGEMENT LTD | 728,123 | $23,730,000 | 0.75% |
ANCHOR CAPITAL ADVISORS LLC | 1,119,060 | $36,470,000 | 0.73% |
Netols Asset Management, Inc. | 137,267 | $4,473,000 | 0.72% |